Rigel Pharmaceuticals
Clinical trials sponsored by Rigel Pharmaceuticals, explained in plain language.
-
New hope for MDS patients Who've run out of options
Disease control Recruiting nowThis early-stage trial is testing an experimental pill called R289 for people with lower-risk myelodysplastic syndromes (MDS), a bone marrow disorder that causes anemia and frequent blood transfusions. The study focuses on patients whose disease hasn't responded to or has stopped…
Phase: PHASE1, PHASE2 • Sponsor: Rigel Pharmaceuticals • Aim: Disease control
Last updated Feb 27, 2026 15:18 UTC
-
Cancer Drug's hidden effects on common medications revealed in new study
Knowledge-focused Recruiting nowThis study aims to understand how the cancer drug olutasidenib affects how the body processes other medications. Researchers will measure blood levels of several test drugs in 16 adult patients with specific genetic mutations in their cancers. The goal is to learn about potential…
Phase: PHASE4 • Sponsor: Rigel Pharmaceuticals • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:42 UTC